M&A · Healthcare · Buyer's industry: Services-Medical Laboratories
Fulgent Genetics, Inc. to acquire Inform Diagnostics
Announced Apr 18, 2022 · Closed · Private target
Deal value$170M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Fulgent Genetics, Inc. (FLGT)
- Target
- Inform Diagnostics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Piper Sandler
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Services-Medical Laboratories